We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

29 hedge funds and large institutions have $2.59M invested in TriSalus Life Sciences Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $2.55M → $2.59M (+$36.1K)

0% more funds holding

Funds holding: 29 → 29 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
3
Calls
$489K
Puts
–
Net Calls
+$489K
Net Calls Change
+$14K

Top Buyers

1
HF
HRT Financial
New York
+$988
2
ETH
Exos TFP Holdings
New York
+$693
3
OMC
Old Mission Capital
Illinois
+$83

Top Sellers

1
IM
Islet Management
New York
-$6.7K
2
BCM
Basso Capital Management
Connecticut
-$3K
3
OCAM
Owl Creek Asset Management
New York
-$1K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1K
5
UBS Group
UBS Group
Switzerland
-$304
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.39M – – –
AGC
2
Angelo Gordon & Co
New York
$961K – – –
MF
3
Magnetar Financial
Illinois
$60K – – –
DM
4
Deerfield Management
New York
$25K – – –
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$21.4K – – –
CS
6
Clear Street
New York
$18K – – –
KC
7
Kepos Capital
New York
$11K – – –
VI
8
Vestcor Inc
New Brunswick, Canada
$11K – – –
MP
9
MSD Partners
New York
$10K – – –
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$10K – – –
KL
11
KIM LLC
Kansas
$8K – – –
Walleye Capital
12
Walleye Capital
New York
$7.93K – – –
BCL
13
Bracebridge Capital LLC
Massachusetts
$7.41K – – –
SCM
14
Shaolin Capital Management
Florida
$6K – – –
AA
15
AQR Arbitrage
Connecticut
$5K – – –
CCM
16
Context Capital Management
California
$5K – – –
ZCA
17
Zeke Capital Advisors
Pennsylvania
$5K – – –
IM
18
Islet Management
New York
$4.89K -$6.7K -98,821 -60%
Balyasny Asset Management
19
Balyasny Asset Management
Illinois
$4.78K – – –
HCM
20
Highbridge Capital Management
New York
$4K – – –
FFAM
21
Forge First Asset Management
Canada
$3.69K +$3.33K +49,133 New
CM
22
CastleKnight Management
New York
$2.17K – – –
HF
23
HRT Financial
New York
$2K +$988 +14,571 +94%
Jane Street
24
Jane Street
New York
$1.3K – – –
AGM
25
Alpine Global Management
New York
$1K – – –
1
2

TLSIW Hedge Fund Activity: Q4 2022 in Review

29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2022, worth a combined $2.59M — up 1.4% from $2.55M a quarter earlier.

Fund positioning in TLSIW was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was HRT Financial, adding an estimated $988. The largest seller was Islet Management, cutting an estimated $6.7K.

  • 29 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $2.59M of TriSalus Life Sciences Warrant stock for Q4 2022, up 1.4% quarter-over-quarter.
  • 3 funds opened new TriSalus Life Sciences Warrant positions in Q4 2022 and 3 closed out, a net change of 0 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q4 2022 was HRT Financial, an estimated $988 added.
  • The largest TriSalus Life Sciences Warrant seller in Q4 2022 was Islet Management, an estimated $6.7K sold.

Based on aggregated 13F filings for Q4 2022.